Investment Criteria

We invest in companies in the biotechnology and medical technology sector with a high level of relevance for the current and future business model of Novo Nordisk.  We invest in companies possessing all the following criteria:

• Pioneering scientific ideas/technologies
• A strong management
• A strong IPR position
• A strong financial prospect
  

Our focus areas of investment are:

• Biotech companies addressing new treatment regimes of Diabetes
• Biotech companies with strong competencies within biopharmaceuticals addressing therapeutics areas such as Inflammation and Haemostasis,
  Protein Delivery Systems and Devices